Cover Image

Safety and efficacy of rituximab in Malawi: a case for multicentre oncology clinical trials in Africa?

Saved in:

Bibliographic Details
Main Author:	Sam M Mbulaiteye (Author)
Format:	Book
Published:	Elsevier, 2021-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical efficacy and safety of rituximab in lupus nephritis
by: Zhong Z, et al.
Published: (2019)

Efficacy and Safety of Rituximab in Children with Refractory Nephrotic Syndrome; A Multicenter Clinical Trial
by: Yo Han Ahn, et al.
Published: (2014)

Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial
by: Stephen Kimani, MBChB, et al.
Published: (2021)

Chronic urticaria as a manifestation of multicentric Castleman disease treated with rituximab
by: Osorio‐Aragón I. Yolanda, et al.
Published: (2024)

Efficacy and safety of rituximab in elderly patients with membranous nephropathy
by: Yanhong Guo, et al.
Published: (2023)

Safety of rituximab on testicles, a double-blindedcontrolled trial in mice
by: Sultan Mogren Al-Mogairen
Published: (2020)

Safety of rituximab in rheumatoid arthritis
by: F. Atzeni, et al.
Published: (2011)

Efficacy and safety of two dose regimens of rituximab for idiopathic membranous nephropathy
by: Zhi-hui Tu, et al.
Published: (2024)

EFFICACY AND SAFETY OF RITUXIMAB IN CHILDREN WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A RETROSPECTIVE STUDY OF THE CASE SERIES
by: Ekaterina I. Alexeeva, et al.
Published: (2016)

Clinical application of circulating cell-free lymphoma DNA for fast and precise diagnosis of Burkitt lymphoma: Precision medicine for sub-Saharan Africa
by: Clara Chamba, et al.
Published: (2023)

Efficacy and Safety of Prolonged Rituximab Treatment in Patients with Systemic Juvenile Idiopathic Arthritis
by: E. I. Alexeeva, et al.
Published: (2013)

Efficacy and Safety of Rituximab in patients with Neuromyelitis Optica Spectrum Disorders: A prospective observation in Iranian Cases.
by: Maral Seyed Ahadi, et al.
Published: (2020)

Efficacy and safety of rituximab dosing for steroid-resistant idiopathic focal segmental glomerulosclerosis: a report of 12 cases
by: Ying-chao Peng, et al.
Published: (2024)

The efficacy and safety of low-dose rituximab in the treatment of pemphigus vulgaris: a cohort study
by: Xingli Zhou, et al.
Published: (2024)

The Efficacy and Safety of Rituximab for the Treatment of Pediatric Autoimmune Neuroinflammatory Disorders at a Single Center
by: Young Jun Ko, et al.
Published: (2020)

Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease
by: Caterina Vacchi, et al.
Published: (2021)

Safety of rituximab in children with auto-immune diseases
by: Bader-Meunier B, et al.
Published: (2008)

The Efficacy and Safety of Rituximab for Childhood Steroid-Dependent Nephrotic Syndrome: A Systematic Review and Meta-Analysis
by: Sidi Liu, et al.
Published: (2021)

Efficacy of rituximab in pediatric pemphigus: A literature review
by: Meera H. Patel, BS, et al.
Published: (2022)

Safety and efficacy of remimazolam besylate in patients undergoing colonoscopy: A multicentre, single-blind, randomized, controlled, phase Ⅲ trial
by: Ximei Wang, et al.
Published: (2022)

A rare HIV-associated hyaline vascular multicentric castleman disease with good early response to single-agent rituximab: A case from Tanzania
by: William Frank Mawalla, et al.
Published: (2022)

Safety and efficacy of rituximab in refractory pediatric Systemic Lupus Erythematosus nephritis: a single-center experience of northern Greece
by: Tzimouli V, et al.
Published: (2011)

Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris
by: Sharon Baum, et al.
Published: (2020)

Tackling noncommunicable diseases in Africa through football: The case of Malawi
by: Allan Kangwerema, et al.
Published: (2023)

Efficacy and safety of acupuncture for the treatment of non-specific acute low back pain: a randomised controlled multicentre trial protocol [ISRCTN65814467]
by: Martinez Barquin Dulce, et al.
Published: (2006)

REACTOGENITY AND SAFETY OF ADSORBED VACCINES AGAINST DIPHTERIA, TETANUS AND PERTUSSIS (DTAP): OBSERVATIONAL MULTICENTRAL TRIAL
by: V.K. Tatochenko, et al.
Published: (2006)

REACTOGENITY AND SAFETY OF ADSORBED VACCINES AGAINST DIPHTERIA, TETANUS AND PERTUSSIS (DTAP): OBSERVATIONAL MULTICENTRAL TRIAL
by: V.K. Tatochenko, et al.
Published: (2006)

Novel Strategies to Improve Rituximab Efficacy in Non-Hodgkin's Lymphomas
by: Massimo Bortolotti, et al.
Published: (2015)

Rituximab mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis
by: Tobias Zrzavy, et al.
Published: (2021)

Satisfaction of oncologic patients hospitalized in centers with and without service of palliative cares: multicentric study
by: Fernando Campaña Castillo, et al.
Published: (2013)

Clinical efficacy of two different doses of rituximab as a treatment option in adult patients with chronic immune thrombocytopenia
by: Dina G. El-Saied, et al.
Published: (2024)

Rituximab Hypersensitivity: From Clinical Presentation to Management
by: Ghada E. Fouda, et al.
Published: (2020)

Erysipelas of the leg (cellulitis) in sub-Saharan Africa: A multicentric study of 562 cases
by: Bayaki Saka, et al.
Published: (2017)

Efficacy and safety of anterior vaginal prolapse treatment using single incision repair system: Multicentric study
by: Marzio Angelo Zullo, et al.
Published: (2022)

The Safety and Efficacy of Phage Therapy: A Systematic Review of Clinical and Safety Trials
by: Helen J. Stacey, et al.
Published: (2022)

Assessment of efficacy, safety, and tolerability of 4-n-butylresorcinol 0.3% cream: an Indian multicentric study on melasma
by: Madan Mohan NT, et al.
Published: (2016)

EXPERIENCE OF CLINICAL USE OF RITUXIMAB IN PATIENT WITH SYSTEMIC JUVENILE ARTHRITIS (A CASE REPORT)
by: E.I. Alexeeva, et al.
Published: (2008)

EXPERIENCE OF CLINICAL USE OF RITUXIMAB IN PATIENT WITH SYSTEMIC JUVENILE ARTHRITIS (A CASE REPORT)
by: E.I. Alexeeva, et al.
Published: (2008)

Efficacy and safety of Yi Shen Fang granules in elderly people with MCI: study protocol for a multicentre, randomized, double-blind, parallel-group, controlled trial
by: Zhongwei Sha, et al.
Published: (2023)

Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial.
by: Asrat Hailu, et al.
Published: (2010)